PLERIXAFOR

PLERIXAFOR was reported 1485 times

PLERIXAFOR is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 BRAIN TERATOMA 8 0.5714
1 CD34 CELL COUNT DECREASED 3 0.3000
2 BONE MARROW HARVEST FAILURE 1 0.2000
3 ACTIVATED PARTIAL THROMBOPLASTIN TIME RATIO DECREASED 1 0.2000
4 NOCTIPHOBIA 4 0.1818
5 DYSMEGAKARYOPOIESIS 2 0.1667
6 BLOOD STEM CELL HARVEST FAILURE 21 0.1419
7 BREVIBACTERIUM INFECTION 1 0.1111
8 PINEAL PARENCHYMAL NEOPLASM MALIGNANT 1 0.0588
9 SCHISTOCYTOSIS 5 0.0575
10 BLOOD STEM CELL HARVEST 2 0.0541
11 FREE HAEMOGLOBIN PRESENT 1 0.0500
12 DELAYED ENGRAFTMENT 6 0.0465
13 PYLOROSPASM 1 0.0455
14 ENGRAFT FAILURE 11 0.0383
15 HAEMATOPOIETIC STEM CELL MOBILISATION 2 0.0312
16 PARAPHARYNGEAL SPACE INFECTION 1 0.0294
17 HOOKWORM INFECTION 1 0.0294
18 BLOOD STEM CELL TRANSPLANT FAILURE 6 0.0279
19 PLASMA CELLS INCREASED 2 0.0270
20 NATURAL KILLER-CELL LYMPHOBLASTIC LYMPHOMA 1 0.0244
21 ENGRAFTMENT SYNDROME 14 0.0237
22 AUDITORY NERVE DISORDER 1 0.0227
23 MYELOMA RECURRENCE 2 0.0200
24 PRIMITIVE NEUROECTODERMAL TUMOUR 1 0.0185
25 HERPES SIMPLEX REACTIVATION 7 0.0184
26 SPLENIC INFECTION FUNGAL 1 0.0179
27 HEPATIC INFECTION FUNGAL 2 0.0167
28 GRAFT VERSUS HOST DISEASE IN INTESTINE 2 0.0154
29 CORYNEBACTERIUM SEPSIS 1 0.0152
30 LEUKOSTASIS SYNDROME 2 0.0150
31 HYPERALBUMINAEMIA 1 0.0122
32 WOUND DECOMPOSITION 2 0.0120
33 POST PROCEDURAL HYPOTENSION 1 0.0118
34 NON-HODGKIN'S LYMPHOMA RECURRENT 1 0.0109
35 MEGAKARYOCYTES DECREASED 1 0.0108
36 BONE MARROW INFILTRATION 4 0.0103
37 LEFT VENTRICULAR DILATATION 5 0.0098
38 INFLUENZA VIRUS TEST POSITIVE 2 0.0095
39 AMYLASE DECREASED 1 0.0090
40 FUSOBACTERIUM INFECTION 1 0.0085
41 MYELODYSPLASTIC SYNDROME WITH EXCESS BLASTS 1 0.0082
42 PLEURAL HAEMORRHAGE 1 0.0079
43 ANORECTAL INFECTION 2 0.0079
44 RESPIRATORY TRACT INFECTION FUNGAL 4 0.0076
45 ASPIRATION BONE MARROW ABNORMAL 1 0.0074
46 RED BLOOD CELL TRANSFUSION 3 0.0073
47 GERM CELL CANCER 1 0.0069
48 VENOOCCLUSIVE LIVER DISEASE 34 0.0069
49 MUCOCUTANEOUS HAEMORRHAGE 1 0.0067
50 ENTEROCOLITIS VIRAL 2 0.0066
51 CENTRAL NERVOUS SYSTEM NEOPLASM 1 0.0062
52 LIP SQUAMOUS CELL CARCINOMA 1 0.0060
53 PNEUMONIA PARAINFLUENZAE VIRAL 1 0.0059
54 PSEUDOMONAL BACTERAEMIA 5 0.0059
55 ABSCESS FUNGAL 1 0.0057
56 INTRACARDIAC MASS 1 0.0056
57 ACQUIRED DIAPHRAGMATIC EVENTRATION 2 0.0056
58 SMALL INTESTINE ADENOCARCINOMA 1 0.0056
59 ACUTE MONOCYTIC LEUKAEMIA 1 0.0055
60 METASTASES TO NERVOUS SYSTEM 1 0.0054
61 HIGH-GRADE B-CELL LYMPHOMA 1 0.0053
62 ACINETOBACTER BACTERAEMIA 1 0.0053
63 SPLEEN CONGESTION 1 0.0052
64 LOWER RESPIRATORY TRACT INFECTION FUNGAL 2 0.0051
65 APLASIA 10 0.0051
66 PNEUMONIA ADENOVIRAL 1 0.0051
67 SPLENIC RUPTURE 8 0.0049
68 SYSTOLIC DYSFUNCTION 5 0.0047
69 STREPTOCOCCAL BACTERAEMIA 5 0.0046
70 BONE MARROW TRANSPLANT REJECTION 1 0.0045
71 VANISHING BILE DUCT SYNDROME 5 0.0045
72 LARYNGEAL DYSPNOEA 1 0.0044
73 ENDOTHELIAL DYSFUNCTION 1 0.0043
74 CENTRAL NERVOUS SYSTEM FUNGAL INFECTION 1 0.0043
75 CEREBRAL NOCARDIOSIS 1 0.0043
76 MUCOSAL INFECTION 1 0.0043
77 BONE MARROW NECROSIS 1 0.0043
78 CANCER IN REMISSION 1 0.0041
79 POST PROCEDURAL FEVER 1 0.0041
80 CLOSTRIDIAL SEPSIS 1 0.0041
81 PHARYNGEAL INFLAMMATION 5 0.0041
82 GASTROINTESTINAL FUNGAL INFECTION 2 0.0039
83 B-CELL APLASIA 1 0.0039
84 CULTURE WOUND POSITIVE 1 0.0038
85 BETA 2 MICROGLOBULIN INCREASED 1 0.0038
86 ASPERGILLOSIS 5 0.0038
87 CULTURE STOOL POSITIVE 1 0.0037
88 ARRHYTHMIA SUPRAVENTRICULAR 4 0.0037
89 LUNG INFECTION PSEUDOMONAL 2 0.0036
90 PERITONSILLAR ABSCESS 3 0.0036
91 SEROUS RETINAL DETACHMENT 3 0.0036
92 BURKHOLDERIA CEPACIA COMPLEX INFECTION 1 0.0035
93 RESPIRATORY TRACT HAEMORRHAGE 2 0.0034
94 PLASMA CELL LEUKAEMIA 2 0.0033
95 ANAL SQUAMOUS CELL CARCINOMA 1 0.0032
96 PARAPROTEINAEMIA 1 0.0032
97 CONGENITAL APLASIA 1 0.0032
98 POST PROCEDURAL FISTULA 1 0.0032
99 MUCOSAL INFLAMMATION 83 0.0032
100 RED BLOOD CELL ABNORMALITY 3 0.0031
101 HAEMATOLOGY TEST ABNORMAL 1 0.0031
102 ADENOVIRUS INFECTION 9 0.0031
103 GASTROENTERITIS EOSINOPHILIC 1 0.0029
104 PROTHROMBIN LEVEL INCREASED 1 0.0029
105 PULMONARY ARTERY DILATATION 1 0.0029
106 FUSARIUM INFECTION 2 0.0029
107 PLASMABLASTIC LYMPHOMA 1 0.0028
108 GRAFT VERSUS HOST DISEASE IN LIVER 2 0.0028
109 COMPLICATIONS OF BONE MARROW TRANSPLANT 1 0.0028
110 HERPES SIMPLEX 18 0.0028
111 CARDIAC AMYLOIDOSIS 3 0.0027
112 ENTEROBACTER SEPSIS 1 0.0027
113 MONOCLONAL IMMUNOGLOBULIN PRESENT 2 0.0026
114 CYSTITIS VIRAL 1 0.0026
115 LIPID METABOLISM DISORDER 1 0.0026
116 ELECTROCARDIOGRAM QRS COMPLEX SHORTENED 1 0.0026
117 B PRECURSOR TYPE ACUTE LEUKAEMIA 1 0.0026
118 METAPNEUMOVIRUS INFECTION 2 0.0026
119 CENTRAL NERVOUS SYSTEM LEUKAEMIA 1 0.0025
120 BLOOD FIBRINOGEN INCREASED 2 0.0025
121 LYMPHANGITIS 2 0.0025
122 LARYNGEAL PAIN 1 0.0025
123 OROPHARYNGEAL PLAQUE 1 0.0025
124 BACTERIAL SEPSIS 8 0.0025
125 THROMBOSIS IN DEVICE 8 0.0024
126 ESCHERICHIA INFECTION 20 0.0024
127 PULMONARY CALCIFICATION 1 0.0024
128 ACUTE GRAFT VERSUS HOST DISEASE 11 0.0024
129 STEM CELL TRANSPLANT 6 0.0024
130 VENOOCCLUSIVE DISEASE 6 0.0024
131 ACTIVATED PARTIAL THROMBOPLASTIN TIME SHORTENED 1 0.0024
132 LATENT TUBERCULOSIS 5 0.0024
133 ACUTE MYELOID LEUKAEMIA RECURRENT 5 0.0023
134 INFLUENZA A VIRUS TEST POSITIVE 1 0.0023
135 TRANSFUSION REACTION 2 0.0023
136 CYTOMEGALOVIRUS INFECTION REACTIVATION 10 0.0023
137 CAECITIS 1 0.0022
138 POST-TRAUMATIC PAIN 1 0.0022
139 STENOTROPHOMONAS INFECTION 3 0.0022
140 BIOPSY BONE MARROW ABNORMAL 1 0.0022
141 CEREBRAL MICROHAEMORRHAGE 1 0.0022
142 FEBRILE NEUTROPENIA 144 0.0022
143 ALPHA HAEMOLYTIC STREPTOCOCCAL INFECTION 2 0.0022
144 PLASMACYTOMA 4 0.0021
145 URINARY TRACT INFECTION ENTEROCOCCAL 2 0.0021
146 PERIPHERAL MOTOR NEUROPATHY 3 0.0021
147 OXYGEN CONSUMPTION INCREASED 5 0.0021
148 NEUTROPENIC INFECTION 2 0.0021
149 BLOOD BICARBONATE INCREASED 1 0.0021
150 MINIMAL RESIDUAL DISEASE 1 0.0021
151 ESCHERICHIA SEPSIS 6 0.0021
152 CARDIAC VALVE VEGETATION 1 0.0021
153 ENDOCARDITIS STAPHYLOCOCCAL 1 0.0020
154 HYPERSPLENISM 1 0.0020
155 ORGANISING PNEUMONIA 10 0.0020
156 PARAINFLUENZAE VIRUS INFECTION 3 0.0020
157 SPLENIC HAEMORRHAGE 1 0.0020
158 PHYSIOTHERAPY 1 0.0019
159 VARICELLA ZOSTER VIRUS INFECTION 4 0.0019
160 SCAPULA FRACTURE 1 0.0019
161 OVARIAN FAILURE 1 0.0019
162 RECTAL PERFORATION 1 0.0019
163 BLOOD IMMUNOGLOBULIN A INCREASED 1 0.0019
164 SCROTAL PAIN 1 0.0018
165 PLASMA CELL MYELOMA RECURRENT 6 0.0018
166 B-CELL LYMPHOMA RECURRENT 1 0.0018
167 PNEUMONIA STREPTOCOCCAL 2 0.0018
168 GRAFT VERSUS HOST DISEASE 13 0.0018
169 GLOMERULONEPHRITIS RAPIDLY PROGRESSIVE 2 0.0018
170 GASTROINTESTINAL ULCER HAEMORRHAGE 2 0.0018
171 RENAL TUBULAR DISORDER 5 0.0018
172 NEUTROPHIL COUNT ABNORMAL 5 0.0018
173 PULMONARY GRANULOMA 2 0.0018
174 LEGIONELLA INFECTION 1 0.0017
175 ROTAVIRUS INFECTION 1 0.0017
176 EJECTION FRACTION 1 0.0017
177 ACUTE LUNG INJURY 2 0.0017
178 JUGULAR VEIN THROMBOSIS 3 0.0017
179 LYMPHATIC DISORDER 1 0.0017
180 STAPHYLOCOCCAL SKIN INFECTION 2 0.0016
181 ARTHRITIS REACTIVE 1 0.0016
182 SUBCUTANEOUS HAEMATOMA 2 0.0016
183 STAPHYLOCOCCAL ABSCESS 1 0.0016
184 THROMBOTIC MICROANGIOPATHY 15 0.0015
185 PLASMA CELL MYELOMA 60 0.0015
186 BLOOD IMMUNOGLOBULIN A DECREASED 1 0.0015
187 ACUTE RESPIRATORY DISTRESS SYNDROME 27 0.0015
188 CYSTITIS HAEMORRHAGIC 6 0.0015
189 CYTOPENIA 18 0.0015
190 ABSCESS ORAL 2 0.0015
191 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 4 0.0014
192 VASCULAR OCCLUSION 3 0.0014
193 CARDIAC ENZYMES INCREASED 1 0.0014
194 THROMBOCYTOSIS 5 0.0014
195 GRAFT VERSUS HOST DISEASE IN SKIN 3 0.0014
196 OTITIS MEDIA ACUTE 1 0.0014
197 ACUTE MYELOID LEUKAEMIA 21 0.0013
198 CREATINE KINASE INCREASED 1 0.0013
199 ALLERGIC COUGH 1 0.0013
200 LABORATORY TEST INTERFERENCE 1 0.0013
201 SARCOIDOSIS 6 0.0013
202 SINUSITIS FUNGAL 1 0.0012
203 HERPES ZOSTER DISSEMINATED 1 0.0012
204 ENTEROCOCCAL SEPSIS 1 0.0012
205 HAEMATOLOGICAL INFECTION 3 0.0012
206 FUNGAL SEPSIS 1 0.0012
207 CYTOMEGALOVIRUS INFECTION 20 0.0012
208 SEPTIC EMBOLUS 1 0.0012
209 COVID-19 IMMUNISATION 1 0.0012
210 BK VIRUS INFECTION 4 0.0012
211 SALMONELLOSIS 2 0.0012
212 ODYNOPHAGIA 7 0.0012
213 SPLENIC INFARCTION 2 0.0011
214 ACUTE CHEST SYNDROME 1 0.0011
215 CLOSTRIDIUM DIFFICILE COLITIS 12 0.0011
216 HYPERLEUKOCYTOSIS 1 0.0011
217 BLOOD ALBUMIN INCREASED 1 0.0011
218 NEUTROPENIC SEPSIS 8 0.0011
219 ORAL FUNGAL INFECTION 3 0.0011
220 WOUND HAEMORRHAGE 4 0.0011
221 LOBAR PNEUMONIA 2 0.0011
222 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 1 0.0011
223 MULTIPLE MYELOMA 5 0.0011
224 ACUTE LYMPHOCYTIC LEUKAEMIA 3 0.0011
225 HUMAN HERPESVIRUS 6 INFECTION 2 0.0011
226 ASCITES 31 0.0011
227 KLEBSIELLA BACTERAEMIA 1 0.0011
228 HYPERMETROPIA 1 0.0011
229 PNEUMONIA CYTOMEGALOVIRAL 2 0.0010
230 GASTROINTESTINAL NECROSIS 3 0.0010
231 HAEMOPHILUS INFECTION 1 0.0010
232 DEVICE RELATED THROMBOSIS 1 0.0010
233 PNEUMONIA FUNGAL 4 0.0010
234 LEUKOCYTOSIS 18 0.0010
235 HYPERURICAEMIA 4 0.0010
236 INTERVERTEBRAL DISC COMPRESSION 1 0.0010
237 PNEUMONIA VIRAL 3 0.0009
238 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 7 0.0009
239 STAPHYLOCOCCAL BACTERAEMIA 4 0.0009
240 HAEMORRHAGIC DISORDER 1 0.0009
241 THERAPY NON-RESPONDER 41 0.0009
242 CLOSTRIDIUM TEST POSITIVE 2 0.0009
243 DIFFUSE LARGE B-CELL LYMPHOMA RECURRENT 2 0.0009
244 OCULAR TOXICITY 1 0.0009
245 BRONCHOPULMONARY ASPERGILLOSIS 7 0.0009
246 PERIRECTAL ABSCESS 1 0.0009
247 MYELODYSPLASTIC SYNDROME 13 0.0009
248 THERAPY PARTIAL RESPONDER 14 0.0009
249 LYMPHOCYTE COUNT ABNORMAL 1 0.0009
250 CLOSTRIDIAL INFECTION 3 0.0009
251 CYTOGENETIC ABNORMALITY 1 0.0009
252 RENAL COLIC 2 0.0009
253 METASTASES TO MENINGES 2 0.0009
254 PELVIC ABSCESS 1 0.0009
255 ISCHAEMIA 4 0.0009
256 NEPHROGENIC DIABETES INSIPIDUS 1 0.0009
257 LICHEN PLANUS 2 0.0009
258 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 2 0.0009
259 PERIPHERAL SENSORY NEUROPATHY 5 0.0009
260 ESCHERICHIA BACTERAEMIA 2 0.0008
261 FEBRILE INFECTION 1 0.0008
262 CHRONIC LYMPHOCYTIC LEUKAEMIA 4 0.0008
263 HAEMATOTOXICITY 8 0.0008
264 PNEUMONIA INFLUENZAL 1 0.0008
265 PRODUCT CONTAMINATION MICROBIAL 1 0.0008
266 PNEUMOCYSTIS JIROVECII INFECTION 1 0.0008
267 ESCHERICHIA TEST POSITIVE 1 0.0008
268 SQUAMOUS CELL CARCINOMA OF SKIN 5 0.0008
269 ENCEPHALITIS VIRAL 1 0.0008
270 PERICARDIAL EFFUSION 19 0.0008
271 TRANSPLANT FAILURE 2 0.0008
272 BLAST CRISIS IN MYELOGENOUS LEUKAEMIA 1 0.0008
273 URINARY TRACT INFECTION BACTERIAL 2 0.0008
274 SEROMA 1 0.0008
275 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 2 0.0008
276 HYPERBILIRUBINAEMIA 8 0.0008
277 BILIARY OBSTRUCTION 1 0.0008
278 NON-HODGKIN'S LYMPHOMA 1 0.0008
279 ASPERGILLUS INFECTION 5 0.0008
280 EPSTEIN-BARR VIRUS INFECTION REACTIVATION 1 0.0008
281 BACTERAEMIA 9 0.0008
282 ANAL FISTULA 4 0.0007
283 PLASMA CELL MYELOMA REFRACTORY 1 0.0007
284 LYMPHOCYTE PERCENTAGE DECREASED 1 0.0007
285 THROMBOCYTOPENIA 82 0.0007
286 CORNEAL ABRASION 1 0.0007
287 GENERALISED OEDEMA 9 0.0007
288 ATELECTASIS 7 0.0007
289 RHONCHI 1 0.0007
290 PERITONEAL HAEMORRHAGE 1 0.0007
291 HYPOMAGNESAEMIA 10 0.0007
292 H1N1 INFLUENZA 1 0.0007
293 BRONCHIAL OBSTRUCTION 1 0.0007
294 MYELITIS TRANSVERSE 1 0.0007
295 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 1 0.0007
296 ATYPICAL MYCOBACTERIAL INFECTION 1 0.0007
297 APPENDIX DISORDER 1 0.0007
298 CONNECTIVE TISSUE DISORDER 1 0.0007
299 INTENSIVE CARE 1 0.0007
300 CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY 1 0.0007
301 POST HERPETIC NEURALGIA 1 0.0007
302 BLOOD MAGNESIUM DECREASED 6 0.0007
303 NOROVIRUS INFECTION 1 0.0007
304 PULMONARY VALVE INCOMPETENCE 1 0.0007
305 SPLENOMEGALY 8 0.0007
306 PNEUMONIA PNEUMOCOCCAL 1 0.0007
307 BLOOD CULTURE POSITIVE 2 0.0007
308 STEROID DIABETES 1 0.0007
309 BONE MARROW DISORDER 2 0.0007
310 DYSAESTHESIA 2 0.0007
311 PROCEDURAL COMPLICATION 5 0.0007
312 HYPOALBUMINAEMIA 5 0.0006
313 BREAST CANCER RECURRENT 2 0.0006
314 COLITIS 24 0.0006
315 ENTEROCOCCAL INFECTION 3 0.0006
316 ACUTE LEUKAEMIA 1 0.0006
317 MEAN CELL HAEMOGLOBIN INCREASED 1 0.0006
318 MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED 1 0.0006
319 RECTAL ABSCESS 1 0.0006
320 ENTEROBACTER INFECTION 1 0.0006
321 KLEBSIELLA INFECTION 3 0.0006
322 HEPATORENAL SYNDROME 1 0.0006
323 SPLEEN DISORDER 1 0.0006
324 SKIN WOUND 1 0.0006
325 GLIOBLASTOMA 1 0.0006
326 BLOOD AMYLASE INCREASED 1 0.0006
327 AMYLOIDOSIS 1 0.0006
328 RETINITIS 1 0.0006
329 FAILURE TO THRIVE 3 0.0006
330 SEPTIC SHOCK 25 0.0006
331 FOLLICULITIS 6 0.0006
332 PSEUDOMONAL SEPSIS 1 0.0006
333 FUNGAL INFECTION 19 0.0006
334 INTERCEPTED PRODUCT STORAGE ERROR 2 0.0006
335 BONE MARROW FAILURE 11 0.0005
336 HYPOPHOSPHATAEMIA 4 0.0005
337 OPPORTUNISTIC INFECTION 1 0.0005
338 PANCYTOPENIA 30 0.0005
339 PULMONARY ALVEOLAR HAEMORRHAGE 3 0.0005
340 PROTEIN TOTAL DECREASED 2 0.0005
341 HYPOPROTEINAEMIA 1 0.0005
342 HEPATIC MASS 1 0.0005
343 EJECTION FRACTION DECREASED 8 0.0005
344 CARDIOPULMONARY FAILURE 2 0.0005
345 PULMONARY HAEMORRHAGE 4 0.0005
346 ELECTROCARDIOGRAM ABNORMAL 4 0.0005
347 PLEURAL EFFUSION 31 0.0005
348 PNEUMONIA STAPHYLOCOCCAL 1 0.0005
349 LARGE INTESTINAL STENOSIS 1 0.0005
350 IMMUNE-MEDIATED HEPATITIS 1 0.0005
351 CAPILLARY LEAK SYNDROME 1 0.0005
352 SUBILEUS 1 0.0005
353 BONE PAIN 28 0.0005
354 ANAEMIA MACROCYTIC 1 0.0005
355 ACUTE RESPIRATORY FAILURE 9 0.0005
356 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 1 0.0005
357 HYPOKALAEMIA 21 0.0005
358 DEVICE RELATED INFECTION 7 0.0005
359 CORONAVIRUS INFECTION 3 0.0005
360 CYTOMEGALOVIRUS VIRAEMIA 2 0.0004
361 PNEUMOCYSTIS JIROVECI PNEUMONIA 1 0.0004
362 BACTERIAL TEST POSITIVE 1 0.0004
363 SUBSTANCE-INDUCED PSYCHOTIC DISORDER 1 0.0004
364 BLOOD PRESSURE SYSTOLIC DECREASED 2 0.0004
365 DISLOCATION OF VERTEBRA 1 0.0004
366 READING DISORDER 1 0.0004
367 PNEUMONIA BACTERIAL 4 0.0004
368 CHRONIC MYELOID LEUKAEMIA 2 0.0004
369 STOMATITIS 26 0.0004
370 APPENDICITIS 4 0.0004
371 DISSEMINATED INTRAVASCULAR COAGULATION 6 0.0004
372 STAPHYLOCOCCAL INFECTION 14 0.0004
373 MULTIPLE ORGAN DYSFUNCTION SYNDROME 12 0.0004
374 ALANINE AMINOTRANSFERASE INCREASED 26 0.0004
375 INTRA-ABDOMINAL HAEMORRHAGE 1 0.0004
376 NEUTROPENIA 57 0.0004
377 FLUID OVERLOAD 6 0.0004
378 CYTOKINE RELEASE SYNDROME 8 0.0004
379 METASTASES TO PERITONEUM 1 0.0004
380 RETINAL ARTERY OCCLUSION 1 0.0004
381 DYSLIPIDAEMIA 2 0.0004
382 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 2 0.0004
383 LACTOSE INTOLERANCE 1 0.0004
384 MEAN CELL VOLUME INCREASED 1 0.0004
385 DIFFUSE LARGE B-CELL LYMPHOMA 3 0.0004
386 MENOPAUSE 1 0.0004
387 ANAPHYLACTIC SHOCK 10 0.0004
388 BLOOD CHLORIDE DECREASED 1 0.0004
389 CATHETER SITE PAIN 1 0.0004
390 GASTROINTESTINAL INFLAMMATION 3 0.0004
391 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 1 0.0004
392 RADICULOPATHY 1 0.0004
393 PROTEIN TOTAL INCREASED 1 0.0004
394 MYCOBACTERIUM AVIUM COMPLEX INFECTION 1 0.0004
395 SUBDURAL HAEMORRHAGE 1 0.0004
396 INTESTINAL ISCHAEMIA 2 0.0004
397 SERUM SICKNESS 1 0.0004
398 PULMONARY OEDEMA 16 0.0004
399 ELECTRIC SHOCK SENSATION 1 0.0004
400 PROCTITIS 1 0.0004
401 RESPIRATORY FAILURE 26 0.0004
402 DRUG TOLERANCE DECREASED 1 0.0004
403 SKIN TOXICITY 2 0.0004
404 RESPIRATORY SYMPTOM 1 0.0004
405 HAEMATOLOGICAL MALIGNANCY 1 0.0004
406 PNEUMATOSIS INTESTINALIS 1 0.0004
407 HERPES VIRUS INFECTION 2 0.0003
408 MULTI-ORGAN FAILURE 6 0.0003
409 PARAESTHESIA ORAL 5 0.0003
410 TUMOUR LYSIS SYNDROME 3 0.0003
411 STRABISMUS 1 0.0003
412 LUNG INFILTRATION 3 0.0003
413 ATYPICAL PNEUMONIA 1 0.0003
414 HEPATITIS CHOLESTATIC 2 0.0003
415 CHEST X-RAY ABNORMAL 1 0.0003
416 BRAIN NATRIURETIC PEPTIDE INCREASED 1 0.0003
417 PORTAL HYPERTENSION 1 0.0003
418 HYPERCALCAEMIA 4 0.0003
419 SEPSIS 36 0.0003
420 EPSTEIN-BARR VIRUS INFECTION 2 0.0003
421 SICKLE CELL ANAEMIA WITH CRISIS 5 0.0003
422 HYPOCALCAEMIA 6 0.0003
423 NON-CARDIAC CHEST PAIN 1 0.0003
424 WHITE BLOOD CELL COUNT ABNORMAL 2 0.0003
425 INFECTION 45 0.0003
426 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 1 0.0003
427 RESPIRATORY TRACT INFECTION 8 0.0003
428 HYPOVENTILATION 1 0.0003
429 LYMPHOCYTE COUNT INCREASED 1 0.0003
430 DEAFNESS NEUROSENSORY 1 0.0003
431 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 1 0.0003
432 ACUTE KIDNEY INJURY 46 0.0003
433 LYME DISEASE 1 0.0003
434 LEFT VENTRICULAR DYSFUNCTION 2 0.0003
435 CELLULITIS 15 0.0003
436 B-CELL LYMPHOMA 1 0.0003
437 BODY TEMPERATURE INCREASED 6 0.0003
438 SUDDEN CARDIAC DEATH 1 0.0003
439 ECCHYMOSIS 2 0.0003
440 TREATMENT FAILURE 24 0.0003
441 GRANULOMA 1 0.0003
442 LARGE INTESTINE PERFORATION 2 0.0003
443 HYPERTRANSAMINASAEMIA 2 0.0003
444 AORTIC STENOSIS 1 0.0003
445 HYPOXIA 10 0.0003
446 FULL BLOOD COUNT ABNORMAL 3 0.0003
447 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 20 0.0003
448 RETINAL HAEMORRHAGE 2 0.0003
449 BODY HEIGHT DECREASED 3 0.0003
450 MOBILITY DECREASED 20 0.0003
451 CHRONIC GRAFT VERSUS HOST DISEASE 1 0.0003
452 PULMONARY ARTERIAL HYPERTENSION 4 0.0003
453 MONOCYTE COUNT INCREASED 1 0.0003
454 RASH PUSTULAR 2 0.0003
455 AMYLASE INCREASED 1 0.0003
456 MEDICAL DEVICE COMPLICATION 2 0.0003
457 RETINOPATHY 1 0.0003
458 BACTERIAL INFECTION 5 0.0003
459 HAEMORRHAGE INTRACRANIAL 4 0.0003
460 NEPHROPATHY TOXIC 3 0.0003
461 HEPATIC FAILURE 8 0.0003
462 CATHETER SITE INFECTION 1 0.0003
463 TROPONIN INCREASED 2 0.0003
464 CONJUNCTIVAL HAEMORRHAGE 1 0.0003
465 LEUKOPENIA 13 0.0003
466 HAEMOLYSIS 2 0.0003
467 TENDONITIS 4 0.0003
468 OESOPHAGEAL CANDIDIASIS 1 0.0003
469 BLOOD DISORDER 2 0.0002
470 SKIN PAPILLOMA 1 0.0002
471 ARTERIOSPASM CORONARY 1 0.0002
472 MUSCLE HAEMORRHAGE 1 0.0002
473 PYREXIA 86 0.0002
474 RHINITIS 2 0.0002
475 RECURRENT CANCER 1 0.0002
476 PLATELET COUNT DECREASED 26 0.0002
477 ANAPHYLACTOID REACTION 1 0.0002
478 OSTEONECROSIS OF JAW 6 0.0002
479 VENTRICULAR TACHYCARDIA 4 0.0002
480 PHARYNGITIS 3 0.0002
481 NEUROPATHY PERIPHERAL 23 0.0002
482 ACUTE CORONARY SYNDROME 2 0.0002
483 ILEUS 3 0.0002
484 EMBOLISM 2 0.0002
485 RED CELL DISTRIBUTION WIDTH INCREASED 1 0.0002
486 SLEEP TERROR 1 0.0002
487 INTESTINAL STENOSIS 1 0.0002
488 SKIN PLAQUE 2 0.0002
489 HALLUCINATION, VISUAL 5 0.0002
490 LIP OEDEMA 1 0.0002
491 FEBRILE BONE MARROW APLASIA 1 0.0002
492 ESCHERICHIA URINARY TRACT INFECTION 1 0.0002
493 CARDIAC FAILURE CHRONIC 1 0.0002
494 FACIAL PARALYSIS 2 0.0002
495 RETCHING 5 0.0002
496 VITAMIN D DECREASED 2 0.0002
497 METASTASES TO CENTRAL NERVOUS SYSTEM 3 0.0002
498 MYOPATHY 2 0.0002
499 HEPATIC LESION 1 0.0002
500 DEEP VEIN THROMBOSIS 15 0.0002
501 ORTHOSTATIC HYPOTENSION 4 0.0002
502 RESPIRATORY SYNCYTIAL VIRUS INFECTION 2 0.0002
503 PULMONARY FUNCTION TEST DECREASED 1 0.0002
504 EOSINOPHILIA 4 0.0002
505 EPISTAXIS 17 0.0002
506 LIGAMENT RUPTURE 1 0.0002
507 LYMPHOCYTE COUNT DECREASED 4 0.0002
508 HAEMOLYTIC ANAEMIA 2 0.0002
509 MENINGITIS ASEPTIC 1 0.0002
510 BLOOD BILIRUBIN INCREASED 6 0.0002
511 NEUTROPHIL COUNT DECREASED 9 0.0002
512 ANAEMIA 42 0.0002
513 IMMUNE THROMBOCYTOPENIA 1 0.0002
514 BRAIN NEOPLASM 2 0.0002
515 THERAPEUTIC RESPONSE DECREASED 13 0.0002
516 LYMPHOPENIA 3 0.0002
517 LEUKAEMIA 2 0.0002
518 SINUS TACHYCARDIA 3 0.0002
519 SPUTUM DISCOLOURED 2 0.0002
520 CARDIAC TAMPONADE 1 0.0002
521 VIRAL INFECTION 7 0.0002
522 SUPRAVENTRICULAR TACHYCARDIA 2 0.0002
523 HYPOVOLAEMIC SHOCK 1 0.0002
524 GASTROINTESTINAL TOXICITY 1 0.0002
525 SINUS BRADYCARDIA 2 0.0002
526 INCORRECT DOSAGE ADMINISTERED 1 0.0002
527 RENAL TUBULAR NECROSIS 2 0.0002
528 RENAL FAILURE 27 0.0002
529 HYPERVOLAEMIA 1 0.0002
530 NIGHTMARE 7 0.0002
531 ABDOMINAL TENDERNESS 1 0.0002
532 HYPERNATRAEMIA 1 0.0002
533 PROTEIN URINE PRESENT 1 0.0002
534 HYPOTHERMIA 2 0.0002
535 PHLEBITIS 1 0.0002
536 LYMPHOMA 3 0.0002
537 MUSCULOSKELETAL CHEST PAIN 3 0.0002
538 WHITE BLOOD CELL COUNT DECREASED 21 0.0002
539 PERIORBITAL OEDEMA 1 0.0002
540 PARTIAL SEIZURES 1 0.0002
541 POLYARTHRITIS 1 0.0002
542 BLOOD LACTATE DEHYDROGENASE INCREASED 3 0.0002
543 NYSTAGMUS 1 0.0002
544 ANAL FISSURE 1 0.0002
545 CLOSTRIDIUM DIFFICILE INFECTION 4 0.0002
546 WHITE BLOOD CELL COUNT INCREASED 7 0.0002
547 GASTROINTESTINAL PAIN 2 0.0002
548 TOOTH DISORDER 4 0.0002
549 HYPOTENSION 36 0.0002
550 HEART RATE ABNORMAL 1 0.0002
551 PNEUMONIA 58 0.0002
552 PULMONARY EMBOLISM 17 0.0002
553 ANGIOPATHY 1 0.0002
554 BLOOD CALCIUM DECREASED 2 0.0002
555 DISEASE PROGRESSION 21 0.0002
556 PERONEAL NERVE PALSY 1 0.0002
557 ATRIAL FIBRILLATION 17 0.0002
558 HERPES ZOSTER 10 0.0002
559 RALES 1 0.0002
560 METABOLIC DISORDER 1 0.0002
561 ELECTROLYTE IMBALANCE 2 0.0002
562 HYPERTRIGLYCERIDAEMIA 1 0.0002
563 TACHYCARDIA 15 0.0002
564 BLOOD IRON DECREASED 2 0.0002
565 PROTHROMBIN TIME PROLONGED 1 0.0002
566 MYELOSUPPRESSION 6 0.0002
567 BLOOD POTASSIUM DECREASED 5 0.0002
568 OEDEMA 9 0.0002
569 HYPERGLYCAEMIA 6 0.0002
570 PRESYNCOPE 4 0.0002
571 NO THERAPEUTIC RESPONSE 2 0.0002
572 ADVERSE EVENT 15 0.0002
573 SMALL INTESTINAL OBSTRUCTION 2 0.0002
574 PIGMENTATION DISORDER 1 0.0002
575 OLIGURIA 1 0.0002
576 BLOOD ALKALINE PHOSPHATASE INCREASED 4 0.0002
577 HYPONATRAEMIA 9 0.0002
578 HEPATITIS 4 0.0002
579 PROCTALGIA 1 0.0002
580 DIARRHOEA 99 0.0002
581 ORAL CANDIDIASIS 2 0.0002
582 HAEMATOCRIT DECREASED 3 0.0002
583 CARDIAC FAILURE ACUTE 1 0.0001
584 MENINGITIS 1 0.0001
585 THROMBOSIS 12 0.0001
586 FREQUENT BOWEL MOVEMENTS 4 0.0001
587 PALLOR 4 0.0001
588 ABNORMAL LOSS OF WEIGHT 1 0.0001
589 GINGIVAL BLEEDING 2 0.0001
590 BLOOD TESTOSTERONE DECREASED 1 0.0001
591 INFARCTION 1 0.0001
592 OFF LABEL USE 127 0.0001
593 ENCEPHALITIS 1 0.0001
594 MENTAL STATUS CHANGES 4 0.0001
595 EXTRASYSTOLES 1 0.0001
596 RENAL FAILURE ACUTE 6 0.0001
597 CEREBRAL HAEMORRHAGE 5 0.0001
598 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 1 0.0001
599 CARDIOGENIC SHOCK 2 0.0001
600 PRURITUS GENERALISED 3 0.0001
601 COMPLICATION ASSOCIATED WITH DEVICE 2 0.0001
602 C-REACTIVE PROTEIN INCREASED 5 0.0001
603 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 4 0.0001
604 MOUTH HAEMORRHAGE 1 0.0001
605 DEHYDRATION 18 0.0001
606 TRANSAMINASES INCREASED 3 0.0001
607 HYDRONEPHROSIS 1 0.0001
608 PAROSMIA 1 0.0001
609 HAEMODYNAMIC INSTABILITY 1 0.0001
610 HYPERTHERMIA 1 0.0001
611 LIPASE INCREASED 1 0.0001
612 FEELING HOT 8 0.0001
613 APNOEA 1 0.0001
614 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 7 0.0001
615 MULTIPLE ALLERGIES 1 0.0001
616 ANAPHYLACTIC REACTION 7 0.0001
617 NASAL DISCOMFORT 1 0.0001
618 PNEUMOTHORAX 2 0.0001
619 BLOOD ALBUMIN DECREASED 1 0.0001
620 RESPIRATORY TRACT CONGESTION 2 0.0001
621 HALLUCINATION, AUDITORY 2 0.0001
622 MULTIPLE SCLEROSIS 6 0.0001
623 ATRIAL FLUTTER 1 0.0001
624 MUSCLE DISORDER 1 0.0001
625 NEURALGIA 3 0.0001
626 BLOOD POTASSIUM INCREASED 2 0.0001
627 POST PROCEDURAL INFECTION 1 0.0001
628 DECUBITUS ULCER 1 0.0001
629 POLYURIA 1 0.0001
630 HICCUPS 1 0.0001
631 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 1 0.0001
632 VOMITING 57 0.0001
633 SPINAL COMPRESSION FRACTURE 1 0.0001
634 BLOOD PRESSURE DECREASED 8 0.0001
635 ABDOMINAL PAIN 28 0.0001
636 HEMIPLEGIA 1 0.0001
637 DRY EYE 6 0.0001
638 COAGULOPATHY 2 0.0001
639 EOSINOPHIL COUNT INCREASED 1 0.0001
640 PALPITATIONS 14 0.0001
641 BLOOD UREA INCREASED 2 0.0001
642 UNEVALUABLE EVENT 9 0.0001
643 CANDIDA INFECTION 2 0.0001
644 HAEMATEMESIS 3 0.0001
645 HEMIPARESIS 2 0.0001
646 CIRCULATORY COLLAPSE 2 0.0001
647 HAEMATURIA 4 0.0001
648 DRUG RESISTANCE 3 0.0001
649 PSEUDOMONAS INFECTION 1 0.0001
650 PSYCHOLOGICAL TRAUMA 1 0.0001
651 PYELONEPHRITIS 1 0.0001
652 NEUROTOXICITY 2 0.0001
653 SPINAL OSTEOARTHRITIS 1 0.0001
654 IMMUNOSUPPRESSION 1 0.0001
655 PURPURA 1 0.0001
656 DRUG ERUPTION 2 0.0001
657 CARDIOTOXICITY 1 0.0001
658 GASTROINTESTINAL INFECTION 1 0.0001
659 ANAL INCONTINENCE 1 0.0001
660 CHILLS 13 0.0001
661 OSTEOMYELITIS 2 0.0001
662 RESPIRATORY ARREST 3 0.0001
663 RETINAL DETACHMENT 1 0.0001
664 NERVE COMPRESSION 1 0.0001
665 DIVERTICULITIS 3 0.0001
666 CONJUNCTIVITIS 2 0.0001
667 HAEMOPTYSIS 3 0.0001
668 HEPATIC STEATOSIS 2 0.0001
669 HAEMOGLOBIN DECREASED 11 0.0001
670 TOXICITY TO VARIOUS AGENTS 18 0.0001
671 DYSPNOEA EXERTIONAL 4 0.0001
672 DISEASE RECURRENCE 5 0.0001
673 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 1 0.0001
674 AFFECT LABILITY 1 0.0001
675 SEIZURE 12 0.0001
676 DIZZINESS POSTURAL 1 0.0001
677 PRODUCT STORAGE ERROR 9 0.0001
678 AUTOIMMUNE DISORDER 1 0.0001
679 NAUSEA 81 0.0001
680 HEPATOMEGALY 1 0.0001
681 LABORATORY TEST ABNORMAL 3 0.0001
682 PRODUCT USE IN UNAPPROVED INDICATION 25 0.0001
683 OVARIAN CYST 1 0.0001
684 CARDIAC FAILURE 8 0.0001
685 PNEUMOCYSTIS JIROVECII PNEUMONIA 1 0.0001
686 APHASIA 3 0.0001
687 BACK PAIN 23 0.0001
688 EYELID PTOSIS 1 0.0001
689 SUBARACHNOID HAEMORRHAGE 1 0.0001
690 SLUGGISHNESS 1 0.0001
691 NEUTROPHIL COUNT INCREASED 1 0.0001
692 MALIGNANT NEOPLASM PROGRESSION 10 0.0001
693 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 1 0.0001
694 DYSPNOEA 55 0.0001
695 CARDIAC ARREST 8 0.0001
696 NERVOUS SYSTEM DISORDER 3 0.0001
697 HAEMORRHAGE 10 0.0001
698 MUSCULOSKELETAL PAIN 5 0.0001
699 INJECTION SITE DISCOMFORT 1 0.0001
700 MOUTH ULCERATION 2 0.0001
701 SUDDEN DEATH 1 0.0001
702 BRADYCARDIA 5 0.0001
703 RECTAL HAEMORRHAGE 4 0.0001
704 CONSTIPATION 20 0.0001
705 SYNCOPE 9 0.0001
706 NERVE INJURY 1 0.0001
707 URINARY RETENTION 3 0.0001
708 MALNUTRITION 1 0.0001
709 INTESTINAL PERFORATION 1 0.0001
710 STATUS EPILEPTICUS 1 0.0001
711 LOWER RESPIRATORY TRACT INFECTION 4 0.0001
712 NEOPLASM 1 0.0001
713 SHOCK 2 0.0001
714 UPPER RESPIRATORY TRACT INFECTION 4 0.0001
715 METASTASES TO LUNG 1 0.0001
716 CHEST PAIN 16 0.0001
717 POST PROCEDURAL HAEMORRHAGE 1 0.0001
718 HEART RATE DECREASED 3 0.0001
719 CHOLECYSTITIS 1 0.0001
720 PRODUCTIVE COUGH 4 0.0001
721 HYPERLIPIDAEMIA 1 0.0001
722 POLYNEUROPATHY 1 0.0001
723 PARAESTHESIA 13 0.0001
724 ADRENAL INSUFFICIENCY 1 0.0001
725 NOCTURIA 1 0.0001
726 SCHIZOPHRENIA 1 0.0001
727 OEDEMA PERIPHERAL 10 0.0001
728 LUNG DISORDER 4 0.0001
729 RESPIRATORY DEPRESSION 1 0.0001
730 INJECTION SITE URTICARIA 2 0.0001
731 INFLUENZA 9 0.0001
732 HEPATIC FUNCTION ABNORMAL 3 0.0001
733 HALLUCINATION 6 0.0001
734 GASTROINTESTINAL DISORDER 7 0.0001
735 HIATUS HERNIA 1 0.0001
736 PLATELET COUNT INCREASED 1 0.0001
737 DEAFNESS 2 0.0001
738 GASTRITIS 2 0.0001
739 SARS-COV-2 TEST POSITIVE 1 0.0001
740 OROPHARYNGEAL PAIN 7 0.0001
741 HYPERTENSION 16 0.0001
742 HYPERSENSITIVITY 14 0.0001
743 ADVERSE REACTION 1 0.0001
744 EAR INFECTION 2 0.0001
745 HAIR TEXTURE ABNORMAL 1 0.0001
746 CARDIAC FAILURE CONGESTIVE 6 0.0001
747 MENSTRUATION IRREGULAR 2 0.0001
748 INJECTION SITE PRURITUS 5 0.0001
749 JOINT RANGE OF MOTION DECREASED 1 0.0001
750 GASTROOESOPHAGEAL REFLUX DISEASE 6 0.0001
751 JAUNDICE 2 0.0001
752 SINUS CONGESTION 1 0.0001
753 THROAT TIGHTNESS 2 0.0001
754 PNEUMONITIS 2 0.0001
755 DECREASED APPETITE 17 0.0001
756 PERIPHERAL COLDNESS 1 0.0001
757 INJECTION SITE REACTION 5 0.0001
758 ARTHROPATHY 4 0.0001
759 RHABDOMYOLYSIS 3 0.0001
760 RENAL IMPAIRMENT 6 0.0001
761 BLOOD TEST ABNORMAL 1 0.0001
762 BLINDNESS UNILATERAL 1 0.0001
763 SEASONAL ALLERGY 1 0.0001
764 NASOPHARYNGITIS 13 0.0001
765 MUSCULAR WEAKNESS 8 0.0001
766 INTERNATIONAL NORMALISED RATIO INCREASED 2 0.0001
767 BRONCHOSPASM 1 0.0001
768 RED BLOOD CELL COUNT DECREASED 2 0.0001
769 CONVULSION 4 0.0001
770 DEATH 60 0.0001
771 HYPOKINESIA 1 0.0001
772 GASTROENTERITIS 1 0.0001
773 CHEST DISCOMFORT 7 0.0001
774 NASAL CONGESTION 4 0.0001
775 COUGH 19 0.0001
776 CARDIOMYOPATHY 1 0.0001
777 URINARY INCONTINENCE 2 0.0001
778 DRUG EFFECT LESS THAN EXPECTED 1 0.0001
779 IMMUNODEFICIENCY 1 0.0001
780 ABDOMINAL DISTENSION 7 0.0001
781 WEIGHT INCREASED 15 0.0001
782 RESPIRATORY DISORDER 2 0.0001
783 BASAL CELL CARCINOMA 1 0.0001
784 SWOLLEN TONGUE 2 0.0001
785 METABOLIC ACIDOSIS 2 0.0001
786 SENSORY DISTURBANCE 1 0.0001
787 HYPERHIDROSIS 8 0.0001
788 RHINORRHOEA 4 0.0001
789 LACTIC ACIDOSIS 2 0.0001
790 BACK DISORDER 1 0.0001
791 BLOOD CREATININE INCREASED 4 0.0001
792 PSYCHOMOTOR HYPERACTIVITY 1 0.0001
793 SKIN DISORDER 2 0.0001
794 NEOPLASM MALIGNANT 4 0.0001
795 RASH 26 0.0001
796 PERICARDITIS 1 0.0001
797 TRANSIENT ISCHAEMIC ATTACK 2 0.0001
798 FLUSHING 6 0.0001
799 ASTHENIA 22 0.0001
800 SCAR 1 0.0001
801 DELIRIUM 2 0.0001
802 COVID-19 10 0.0001
803 METASTASES TO LIVER 1 0.0001
804 VISUAL IMPAIRMENT 7 0.0001
805 INJECTION SITE ERYTHEMA 7 0.0001
806 GALLBLADDER DISORDER 1 0.0001
807 ELECTROCARDIOGRAM QT PROLONGED 2 0.0001
808 RASH PRURITIC 3 0.0001
809 RESTLESS LEGS SYNDROME 1 0.0001
810 DYSURIA 2 0.0001
811 AGRANULOCYTOSIS 1 0.0001
812 URTICARIA 9 0.0001
813 CARDIAC DISORDER 5 0.0001
814 OXYGEN SATURATION DECREASED 3 0.0001
815 HEPATIC CIRRHOSIS 1 0.0001
816 MYALGIA 9 0.0001
817 BLOOD URINE PRESENT 1 0.0001
818 PROTEINURIA 1 0.0001
819 INSOMNIA 14 0.0001
820 FEELING JITTERY 1 0.0001
821 PULMONARY FIBROSIS 1 0.0001
822 DRUG PRESCRIBING ERROR 1 0.0001
823 GENERAL PHYSICAL HEALTH DETERIORATION 6 0.0001
824 HERNIA 1 0.0001
825 FATIGUE 40 0.0001
826 ORAL HERPES 1 0.0001
827 KIDNEY INFECTION 1 0.0001
828 ACTIVITIES OF DAILY LIVING IMPAIRED 1 0.0001
829 CATARACT 3 0.0001
830 BLOOD PRESSURE ABNORMAL 1 0.0001
831 FULL BLOOD COUNT DECREASED 1 0.0000
832 CONFUSIONAL STATE 8 0.0000
833 PRODUCT ADMINISTRATION ERROR 1 0.0000
834 ILL-DEFINED DISORDER 3 0.0000
835 RIB FRACTURE 1 0.0000
836 DIZZINESS 24 0.0000
837 PRODUCT USE ISSUE 9 0.0000
838 GASTROINTESTINAL HAEMORRHAGE 4 0.0000
839 LOSS OF CONSCIOUSNESS 6 0.0000
840 LIVER FUNCTION TEST INCREASED 1 0.0000
841 POOR QUALITY SLEEP 1 0.0000
842 INCORRECT PRODUCT ADMINISTRATION DURATION 1 0.0000
843 PRODUCT DOSE OMISSION 3 0.0000
844 PRODUCT PRESCRIBING ISSUE 1 0.0000
845 APPLICATION SITE PAIN 1 0.0000
846 ANGIOEDEMA 2 0.0000
847 LIVER DISORDER 2 0.0000
848 RASH MACULO-PAPULAR 1 0.0000
849 HEPATOTOXICITY 1 0.0000
850 HEADACHE 28 0.0000
851 RASH PAPULAR 1 0.0000
852 THROAT IRRITATION 2 0.0000
853 ADVERSE DRUG REACTION 4 0.0000
854 PANCREATITIS ACUTE 1 0.0000
855 VISION BLURRED 6 0.0000
856 TINNITUS 2 0.0000
857 SKIN DISCOLOURATION 2 0.0000
858 RENAL DISORDER 2 0.0000
859 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 1 0.0000
860 COGNITIVE DISORDER 2 0.0000
861 ARRHYTHMIA 2 0.0000
862 OCULAR HYPERAEMIA 2 0.0000
863 COMA 2 0.0000
864 BLOOD PRESSURE FLUCTUATION 1 0.0000
865 DIABETIC KETOACIDOSIS 1 0.0000
866 CONTUSION 4 0.0000
867 INTERSTITIAL LUNG DISEASE 2 0.0000
868 DRUG INEFFECTIVE 54 0.0000
869 CEREBRAL INFARCTION 1 0.0000
870 ENCEPHALOPATHY 1 0.0000
871 ABASIA 1 0.0000
872 ABDOMINAL PAIN LOWER 1 0.0000
873 HYPOPHAGIA 1 0.0000
874 SINUSITIS 4 0.0000
875 THERAPY CESSATION 2 0.0000
876 PERIPHERAL SWELLING 6 0.0000
877 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 1 0.0000
878 ILLNESS 4 0.0000
879 SKIN ULCER 1 0.0000
880 DIPLOPIA 1 0.0000
881 PANCREATITIS 2 0.0000
882 SKIN LESION 1 0.0000
883 INFLUENZA LIKE ILLNESS 3 0.0000
884 RESPIRATORY DISTRESS 1 0.0000
885 ABNORMAL DREAMS 1 0.0000
886 FEELING COLD 1 0.0000
887 NECK PAIN 2 0.0000
888 ABDOMINAL DISCOMFORT 6 0.0000
889 HYPERSOMNIA 1 0.0000
890 LETHARGY 2 0.0000
891 BLOOD CREATINE PHOSPHOKINASE INCREASED 1 0.0000
892 BALANCE DISORDER 3 0.0000
893 MYOCARDIAL INFARCTION 6 0.0000
894 LIVER FUNCTION TEST ABNORMAL 1 0.0000
895 PSYCHOTIC DISORDER 1 0.0000
896 HYPOAESTHESIA 5 0.0000
897 CORONARY ARTERY DISEASE 1 0.0000
898 EPILEPSY 1 0.0000
899 DRUG ADMINISTRATION ERROR 1 0.0000
900 LIMB DISCOMFORT 1 0.0000
901 DRUG-INDUCED LIVER INJURY 1 0.0000
902 CYSTITIS 1 0.0000
903 MOVEMENT DISORDER 1 0.0000
904 NIGHT SWEATS 1 0.0000
905 AMNESIA 2 0.0000
906 PRODUCT DOSE OMISSION ISSUE 9 0.0000
907 DYSPEPSIA 3 0.0000
908 OSTEONECROSIS 1 0.0000
909 EYE DISORDER 1 0.0000
910 INFUSION RELATED REACTION 2 0.0000
911 TREMOR 5 0.0000
912 LIP SWELLING 1 0.0000
913 SOMNOLENCE 6 0.0000
914 HEPATIC ENZYME INCREASED 2 0.0000
915 ERYTHEMA 6 0.0000
916 MEMORY IMPAIRMENT 4 0.0000
917 ARTHRALGIA 12 0.0000
918 NEOPLASM PROGRESSION 1 0.0000
919 WEIGHT DECREASED 8 0.0000
920 PRURITUS 11 0.0000
921 RASH MACULAR 1 0.0000
922 HYPERKALAEMIA 1 0.0000
923 LYMPHADENOPATHY 1 0.0000
924 NO ADVERSE EVENT 5 0.0000
925 DRUG EFFECT INCOMPLETE 1 0.0000
926 PANIC ATTACK 1 0.0000
927 UNDERDOSE 2 0.0000
928 RESTLESSNESS 1 0.0000
929 BRONCHITIS 2 0.0000
930 EYE SWELLING 1 0.0000
931 DYSARTHRIA 1 0.0000
932 INTESTINAL OBSTRUCTION 1 0.0000
933 DIABETES MELLITUS 2 0.0000
934 PAIN 16 0.0000
935 ARTHRITIS 2 0.0000
936 DEPRESSED LEVEL OF CONSCIOUSNESS 1 0.0000
937 FEELING ABNORMAL 6 0.0000
938 ANXIETY 7 0.0000
939 CARDIO-RESPIRATORY ARREST 1 0.0000
940 OSTEOARTHRITIS 1 0.0000
941 URINARY TRACT INFECTION 4 0.0000
942 HYPOACUSIS 1 0.0000
943 MALAISE 10 0.0000
944 DEPRESSION 5 0.0000
945 NEPHROLITHIASIS 1 0.0000
946 MUSCLE SPASMS 4 0.0000
947 BREAST CANCER 2 0.0000
948 FALL 7 0.0000
949 RASH ERYTHEMATOUS 1 0.0000
950 GAIT DISTURBANCE 4 0.0000
951 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1 0.0000
952 DRUG INTOLERANCE 2 0.0000
953 HYPOGLYCAEMIA 1 0.0000
954 HEART RATE INCREASED 2 0.0000
955 FLUID RETENTION 1 0.0000
956 HOSPITALISATION 3 0.0000
957 ABDOMINAL PAIN UPPER 4 0.0000
958 INFLAMMATION 1 0.0000
959 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1 0.0000
960 SPEECH DISORDER 1 0.0000
961 DEPRESSED MOOD 1 0.0000
962 ASPARTATE AMINOTRANSFERASE INCREASED 1 0.0000
963 DISTURBANCE IN ATTENTION 1 0.0000
964 MEDICATION ERROR 1 0.0000
965 BLISTER 1 0.0000
966 EYE PAIN 1 0.0000
967 CEREBROVASCULAR ACCIDENT 3 0.0000
968 FLATULENCE 1 0.0000
969 PAIN IN EXTREMITY 5 0.0000
970 CONDITION AGGRAVATED 5 0.0000
971 ALOPECIA 3 0.0000
972 BURNING SENSATION 1 0.0000
973 SLEEP DISORDER 1 0.0000
974 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 1 0.0000
975 OVERDOSE 3 0.0000
976 AGITATION 1 0.0000
977 DYSGEUSIA 1 0.0000
978 HOT FLUSH 1 0.0000
979 DRUG DOSE OMISSION 2 0.0000
980 SKIN EXFOLIATION 1 0.0000
981 INTENTIONAL PRODUCT MISUSE 1 0.0000
982 INTENTIONAL PRODUCT USE ISSUE 1 0.0000
983 MUSCULOSKELETAL STIFFNESS 1 0.0000
984 JOINT SWELLING 1 0.0000
985 PSORIASIS 1 0.0000
986 BLOOD PRESSURE INCREASED 1 0.0000
987 INJECTION SITE PAIN 2 0.0000
988 DRUG INTERACTION 1 0.0000
989 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1 0.0000
990 BLOOD GLUCOSE INCREASED 1 0.0000